Superior Activity of Fusion Protein scFvRit:sFasL Over Cotreatment With Rituximab and Fas Agonists

Cancer Research - United States
doi 10.1158/0008-5472.can-07-5171
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Cotreatment With Methotrexate in Routine Care Patients With Rheumatoid Arthritis Receiving Biological Treatment Yields Better Outcomes Over Time

RMD Open
RheumatologyAllergyImmunology
2019English

Genetic Diversity and Evolution of Human Metapneumovirus Fusion Protein Over Twenty Years

Virology Journal
VirologyInfectious Diseases
2009English

The Recombinant Expression and Activity Detection of MAF-1 Fusion Protein

Scientific Reports
Multidisciplinary
2015English

Structure of the Ebola Virus Envelope Protein MPER/TM Domain and Its Interaction With the Fusion Loop Explains Their Fusion Activity

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2017English

A CD47-blocking TRAIL Fusion Protein With Dual Pro-Phagocytic and Pro-Apoptotic Anticancer Activity

British Journal of Haematology
Hematology
2013English

Prolonged Activity of Factor IX as a Monomeric Fc Fusion Protein

Blood
BiochemistryImmunologyCell BiologyHematology
2010English

Chaperone Activity of Human Small Heat Shock Protein-GST Fusion Proteins

Cell Stress and Chaperones
BiochemistryCell Biology
2017English

Photo Regulation of Kinesin Motor Activity Utilizing Photochromic Dronpa-Loop11 Fusion Protein

Biophysical Journal
Biophysics
2017English

Cotreatment With a Novel Phosphoinositide Analogue Inhibitor and Carmustine Enhances Chemotherapeutic Efficacy by Attenuating AKT Activity in Gliomas

Cancer
Cancer ResearchOncology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy